The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12‐gene DCIS score™ result

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|111|8|935-940

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.8, 2015-06, pp. : 935-940

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Selection for Patients with Ductal Carcinoma In Situ (DCIS) of the Breast Using the University of Southern California/Van Nuys (USC/VNPI) Prognostic Index

By  

THE BREAST JOURNAL, Vol. 21, Iss. 2, 2015-03 ,pp. : 127-132

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ductal Carcinoma in situ of the Breast in Israeli Women Treated by Breast-Conserving Surgery Followed by Radiation Therapy

By  

Oncology, Vol. 76, Iss. 1, 2008-11 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

Genetics patients' perspectives on clinical genomic testing

By McGowan Michelle L   Glinka Allison   Highland Janelle   Asaad George   Sharp Richard R  

Personalized Medicine, Vol. 10, Iss. 4, 2013-06 ,pp. : 339-347

Future Medicine

Access to resources Recommend Favorite

Erlotinib and Radiation Therapy for Elderly Patients with Esophageal Cancer - Clinical and Correlative Results from a Prospective Multicenter Phase 2 Trial

By  

Oncology, Vol. 85, Iss. 1, 2013-07 ,pp. : 53-58

Karger

Access to resources Recommend Favorite

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 5, 2015-12 ,pp. : 476-480

John Wiley & Sons Inc

Access to resources Recommend Favorite